- A $996,413 Phase II SBIR grant from the NSF advances ReSuture’s efforts to quantify operative performance through simulated surgical platforms, capacitive sensing, and machine learning
- ReSuture’s proposed technology – a combination of lifelike physical simulations, novel sensors, and robust data analysis – is addressing a universal market need that has been unsolved for decades
- ReSuture’s early working solutions have been adopted by device manufacturers W.L. Gore, Teleflex Medical, Becton Dickinson, Endologix, and surgical residency programs at Tulane Medical Center, McMaster University, and the Mayo Clinic
Category Archives: AZBio News
National Science Foundation awards $90.8M to ASU to advance X-ray science
World’s first Compact X-ray Free Electron Laser to be constructed at Arizona State
The National Science Foundation today announced $90.8 million in funding to Arizona State University — the largest NSF research award in the university’s history — to advance groundbreaking research in X-ray science.Continue reading
Parkinson’s Foundation Receives Grant to Fund Critical Research, Genetic Testing and Counseling
Simone Charitable Foundation Awards Nearly $800,000 to Assist People with Parkinson’s in ArizonaContinue reading
AZBio CEO Talks Health Innovation on The Business Roundtable with Matt Battaglia
AZBio President and CEO, Joan Koerber-Walker , joined host Matt Battaglia of 1100 KFNX for The Business Round Table. Listen in to learn about health innovations being developed in Arizona and how AZBio is working to help Arizona become a top-ten bioscience state.Continue reading
Globally Renowned Research Scientist Joins Phoenix Children’s, University of Arizona College of Medicine – Phoenix
Vladimir Kalinichenko, MD, PhD Takes up Post as Director, Strengthens Focus on Bench-to-Bedside ResearchContinue reading
Startup Metfora to advance development of AI-enabled diagnostic technology
TUCSON, AZ – University of Arizona startup Metfora, LLC has announced that it is the recipient of a Small Business Innovation Research (SBIR) Phase l Award from the National Science Foundation to pursue the detection of chronic diseases via multiplex analysis of circulating metabolites. The company will receive a one-year grant of $255,706 to expand a pioneering diagnostic technology originally developed at the UArizona College of Medicine – Tucson.Continue reading
UArizona COVID-19 Treatment Takes Next Step Toward Public Impact via License to Pharmaceutical Company
A compound developed by researchers at the R. Ken Coit College of Pharmacy moves one step closer to commercialization with licensing agreement.
A study conducted by researchers at the University of Arizona Health Sciences and the University of Illinois found that viral loads of the SARS-CoV-2 virus can be reduced by small molecule PLpro inhibitors.Continue reading
Lilly Cuts Insulin Prices by 70% and Caps Patient Insulin Out-of-Pocket Costs at $35 Per Month
INDIANAPOLIS, March 1, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less per month. Lilly is taking these actions to make it easier to access Lilly insulin and help Americans who may have difficulty navigating a complex healthcare system that may keep them from getting affordable insulin. (Download PDF)
Dignity Health St. Joseph’s Hospital and Medical Center launches new initiative to address health disparities of African Americans with chronic kidney disease
PHOENIX, Feb. 27, 2023 (GLOBE NEWSWIRE) — Dignity Health St. Joseph’s Hospital and Medical Center has launched a new initiative to address race-based algorithms in early diagnosis of chronic kidney disease. The launch of the program marks a significant step towards removing barriers that have long plagued racial and ethnic minorities, particularly African Americans. The initiative is being led by CommonSpirit Health, of which St. Joseph’s is a member.Continue reading
HonorHealth Research Institute implants first state-of-the-art modified pacemaker system in an Arizona patient
Two-device system is designed to detect and treat ventricular fibrillation, providing heart patients with a permanent, potentially life-saving way to keep their heart from beating out of control.Continue reading